Pyxis Oncology Inc (PYXS)
1.5350 +0.0350 (+2.33%) 14:55 ET [NASDAQ]
1.5300 x 362 1.5400 x 300
Realtime by (Cboe BZX)
1.5300 x 362 1.5400 x 300
Realtime 1.5000 unch (unch) 09:29 ET
for Tue, Jan 21st, 2025
Results
download Want to compare other data? Select FieldsSymbol | PYXS | TARA | GUTS | ||
Company | Pyxis Oncology Inc | Artara Therapeutics Inc | Fractyl Health Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.5000 | 4.55 | 1.8500 | ||
High | 1.5600 | 4.82 | 1.8898 | ||
Low | 1.4800 | 4.55 | 1.7800 | ||
Last | 1.5350 | 4.73 | 1.8300 | ||
Change | +0.0350 | +0.18 | +0.0300 | ||
% Change | +2.33% | +3.96% | +1.67% | ||
Volume | 282,628 | 284,014 | 256,469 | ||
20-Day Average Volume | 786,703 | 448,773 | 371,626 | ||
Previous Close | 1.5000 | 4.55 | 1.8000 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 1.5918 | 5.32 | 1.9360 | ||
20-Day Raw Stochastic | 36.05% | 13.31% | 15.69% | ||
20-Day Relative Strength | 37.65% | 49.77% | 42.93% | ||
Weighted Alpha | -45.21 | -1.35 | -78.82 | ||
Today's Opinion | 100% Sell | 80% Buy | 100% Sell | ||
Previous Opinion | 100% Sell | 80% Buy | 100% Sell | ||
Last Month's Opinion | 100% Sell | 88% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.98% since 01/13/25 | -10.83% since 01/13/25 | -6.15% since 01/13/25 | ||
Low | 1.3900 on 01/16/25 | 4.51 on 01/17/25 | 1.7700 on 01/17/25 | ||
High | 1.5800 on 01/17/25 | 5.37 on 01/14/25 | 1.9873 on 01/14/25 | ||
1-Month | |||||
%Chg | -8.58% since 12/20/24 | -12.15% since 12/20/24 | +2.23% since 12/20/24 | ||
Low | 1.3900 on 01/16/25 | 4.51 on 01/17/25 | 1.7700 on 01/17/25 | ||
High | 1.8200 on 01/07/25 | 6.20 on 01/06/25 | 2.2600 on 01/02/25 | ||
3-Month | |||||
%Chg | -58.02% since 10/21/24 | +135.57% since 10/21/24 | -29.89% since 10/21/24 | ||
Low | 1.3900 on 01/16/25 | 1.78 on 10/23/24 | 1.7500 on 12/20/24 | ||
High | 5.3899 on 11/11/24 | 10.48 on 12/05/24 | 3.4810 on 10/30/24 | ||
6-Month | |||||
%Chg | -55.60% since 07/19/24 | +112.33% since 07/19/24 | -53.55% since 07/19/24 | ||
Low | 1.3900 on 01/16/25 | 1.60 on 10/10/24 | 1.7400 on 08/08/24 | ||
High | 5.3899 on 11/11/24 | 10.48 on 12/05/24 | 4.3700 on 07/29/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 89,199 | 93,866 | 86,578 | ||
Shares Outstanding, K | 59,466 | 20,630 | 48,099 | ||
Annual Sales | 0 | 0 | 120,000 | ||
Annual Net Income | -73,790,000 | -40,420,000 | -77,090,000 | ||
Last Quarter Sales | 0 | 0 | 10,000 | ||
Last Quarter Net Income | -17,300,000 | -11,220,000 | -23,170,000 | ||
60-Month Beta | 1.06 | 1.56 | N/A | ||
Per-Share Information | |||||
Most Recent Earnings | -0.35 on 11/12/24 | -0.50 on 11/12/24 | -0.48 on 11/12/24 | ||
Latest Earnings Date | 11/12/24 | 03/12/25 | 11/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |